Zhao Fei-Yi, Kennedy Gerard A, Spencer Sarah J, Conduit Russell, Zhang Wen-Jing, Fu Qiang-Qiang, Zheng Zhen
School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia.
Department of Nursing, School of International Medical Technology, Shanghai Sanda University, Shanghai, China.
Front Psychiatry. 2022 Apr 15;13:863134. doi: 10.3389/fpsyt.2022.863134. eCollection 2022.
Due to concerns about risks associated with antidepressants and/or hypnotics, complementary therapies such as acupuncture have been sought by patients with active or previous depression to manage insomnia. This systematic review aimed to clarify if acupuncture is effective and safe enough to be recommended as an alternative or adjuvant therapy to standard care in ameliorating concomitant or residual insomnia, two types of insomnia associated with depression.
Randomized controlled trials (RCTs) of depression-related insomnia (DI) treatment acupuncture . waitlist-control or placebo-/sham-acupuncture and RCTs of DI treatment acupuncture alone or combined with standard care [Western pharmacotherapy and/or cognitive-behavioral therapy (CBT)] . standard care alone were searched for from seven databases from inception to December 2021. Cochrane criteria were followed.
Twenty-one studies involving 1,571 participants were analyzed. For insomnia as a major symptom of active depression, meta-analyses suggested that acupuncture significantly reduced the global scores of both the Pittsburg Sleep Quality Index (PSQI) [MD = -3.12, 95% CI (-5.16, -1.08), < 0.01] and Hamilton Depression Scale (HAMD) [SMD = -2.67, 95% CI (-3.51, -1.84), < 0.01], in comparison with placebo-acupuncture. When compared with conventional pharmacotherapy (antidepressants and/or hypnotics), the results favored acupuncture in decreasing PSQI [MD = -1.17, 95% CI (-2.26, -0.08), = 0.03] and HAMD [SMD = -0.47, 95% CI (-0.91, -0.02), = 0.04]. Acupuncture was comparable to conventional pharmacotherapy in reducing scores of each domain of PSQI. For insomnia as a residual symptom of previous or partially remitted depression, acupuncture conferred a very limited, non-significant therapeutic advantage against sham-/placebo-acupuncture. Whether acupuncture has an add-on effect to conventional pharmacotherapy in this type of insomnia has not been investigated. Also, no study was available to address the efficacy differences between acupuncture and CBT or the synergistic effect of these two therapies.
There is a low to moderate level of evidence supporting acupuncture as a safe and effective remedy alternative to or adjuvant to conventional pharmacotherapy (antidepressant and/or hypnotic) in improving insomnia and other depression symptoms among patients with active depression. Furthermore, the patients' complaint of disrupted sleep continuity is most likely to benefit from acupuncture. The benefit of acupuncture on residual insomnia associated with previous or partially remitted depression is limited. Future acupuncture studies need to consider applying optimal dosage and addressing deficiencies in trial quality. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021269880, PROSPERO, identifier: CRD42021269880.
由于担心抗抑郁药和/或催眠药的相关风险,患有当前或既往抑郁症的患者寻求诸如针灸等补充疗法来治疗失眠。本系统评价旨在明确针灸是否足够有效和安全,从而被推荐作为标准治疗的替代或辅助疗法,以改善两种与抑郁症相关的失眠症,即伴随性失眠或残留性失眠。
从7个数据库自建库至2021年12月搜索抑郁症相关失眠(DI)治疗的随机对照试验(RCT):针灸与等待列表对照或安慰剂/假针灸对比,以及DI治疗单独使用针灸或联合标准治疗[西医药物治疗和/或认知行为疗法(CBT)]与单独标准治疗对比。遵循Cochrane标准。
分析了涉及1571名参与者的21项研究。对于作为当前抑郁症主要症状的失眠,荟萃分析表明,与安慰剂针灸相比,针灸显著降低了匹兹堡睡眠质量指数(PSQI)的总体评分[MD = -3.12,95%CI(-5.16,-1.08),P < 0.01]和汉密尔顿抑郁量表(HAMD)评分[SMD = -2.67,95%CI(-3.51,-1.84),P < 0.01]。与传统药物治疗(抗抑郁药和/或催眠药)相比,结果显示针灸在降低PSQI评分[MD = -1.17,95%CI(-2.26,-0.08),P = 0.03]和HAMD评分[SMD = -0.47,95%CI(-0.91,-0.02),P = 0.04]方面更具优势。在降低PSQI各领域评分方面,针灸与传统药物治疗相当。对于作为既往或部分缓解抑郁症残留症状的失眠,与假/安慰剂针灸相比,针灸的治疗优势非常有限且无统计学意义。尚未研究针灸在这类失眠中对传统药物治疗是否具有附加作用。此外,没有研究探讨针灸与CBT之间的疗效差异或这两种疗法的协同作用。
有低到中等水平的证据支持针灸作为传统药物治疗(抗抑郁药和/或催眠药)的安全有效替代或辅助疗法,用于改善当前抑郁症患者的失眠及其他抑郁症状。此外,患者对睡眠连续性中断的抱怨最有可能从针灸中获益。针灸对与既往或部分缓解抑郁症相关的残留性失眠的益处有限。未来的针灸研究需要考虑应用最佳剂量并解决试验质量方面的不足。https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021269880,PROSPERO,标识符:CRD42021269880